We are live on
!
Find out more
Zevra Therapeutics
ZVRA
ZVRA
32 hedge funds and large institutions have $30.1M invested in Zevra Therapeutics in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
69% more capital invested
Capital invested by funds: $17.8M → $30.1M (+$12.3M)
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
25% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 8
11% less funds holding
Funds holding: 36 → 32 (-4)
Holders
32
Holders Change
-4
Holders Change %
-11.11%
% of All Funds
0.8%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
4
Increased
10
Reduced
8
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$501K |
| 2 |
BlackRock
New York
|
+$329K |
| 3 |
Morgan Stanley
New York
|
+$97.6K |
| 4 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
+$63.4K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
+$38.8K |
Top Sellers
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$152K |
| 2 |
WS
Wedbush Securities
Los Angeles,
California
|
-$59K |
| 3 |
Millennium Management
New York
|
-$44.3K |
| 4 |
MC
Menta Capital
San Francisco,
California
|
-$23.5K |
| 5 |
Barclays
London,
United Kingdom
|
-$9.9K |
